Aldeyra Therapeutics Revenue

Biotechnology Research • Lexington, Massachusetts, United States • 11-20 Employees

Aldeyra Therapeutics revenue & valuation

Annual revenue	$1,605,680
Revenue per employee	$115,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,200,000
Total funding	$125,000,000

Key Contacts at Aldeyra Therapeutics

Charles Montgomery

Senior Director, Cmc

Todd Brady

Chief Executive Officer

Company overview

Headquarters	131 Hartwell Avenue, Suite 320, Lexington, Massachusetts 02421, US
Phone number	+17817614904
Websites	aldeyra.com theruthgroup.com
NAICS	541714
SIC	873
Founded	2004
Employees	11-20
Socials

Aldeyra Therapeutics Email Formats

Aldeyra Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@aldeyra.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@aldeyra.com	100%

About Aldeyra Therapeutics

Aldeyra Therapeutics discovers and develops innovative therapies designed to treat immune-mediated diseases. Our approach is to develop therapies that modulate immunological systems, instead of inhibiting or activating single targets, with the goal of optimizing multiple pathways at once while minimizing toxicity. Two of our lead product candidates, reproxalap and ADX-629, target pre-cytokine, systems-based mediators of inflammation known as RASP (reactive aldehyde species). Reproxalap is in Phase 3 clinical trials in patients with dry eye disease and allergic conjunctivitis. ADX-629, an orally administered RASP modulator, is in Phase 2 proof-of-concept clinical trials in psoriasis, asthma, and COVID-19. Our pipeline also includes ADX-2191 (intravitreal methotrexate 0.8%), in development for the prevention of proliferative vitreoretinopathy and the treatment of retinitis pigmentosa and primary vitreoretinal lymphoma.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Manager

C-Suite

Director

Employees by Department

Aldeyra Therapeutics has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Aldeyra Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-05-28	14	$125,000,000

Funding Insights

$125,000,000

Total funding amount

$125,000,000

Most recent funding amount

Number of funding rounds

Aldeyra Therapeutics Tech Stack

Discover the technologies and tools that power Aldeyra Therapeutics's digital infrastructure, from frameworks to analytics platforms.

jQuery UI

JavaScript libraries

Elementor

Page builders

Microsoft 365

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

GeneratePress

WordPress themes

PHP

Programming languages

WordPress

Blogs

Yoast SEO

SEO

GoDaddy

Hosting

Nginx

Reverse proxies

Frequently asked questions

Aldeyra Therapeutics is located in Lexington, Massachusetts, US.

You can reach Aldeyra Therapeutics at +17817614904.

Aldeyra Therapeutics generates an estimated annual revenue of $1,605,680. This revenue figure reflects the company's market position and business performance in its industry.

Aldeyra Therapeutics has an estimated valuation of $5,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Aldeyra Therapeutics was founded in 2004, making it 22 years old. The company has established itself as a significant player in its industry over this time.

Aldeyra Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Aldeyra Therapeutics has raised a total of $125,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Aldeyra Therapeutics

Charles Montgomery

Senior Director, Cmc

Todd Brady

Chief Executive Officer

4.8

40,000 users